Learn More
Medchemexpress LLC Clarithromycin | 81103-11-9 | 99.9% | 747.95 | 200 MG

Supplier: Medchemexpress LLC HY17508200MG
Clarithromycin possesses a broad spectrum of antimicrobial activity. It inhibits CYP3A4-catalyzed triazolam alpha-hydroxylation with an IC50 (Ki) value of 56 (43) μM and significantly inhibits the hERG potassium current. Clarithromycin affects autophagic flux by impairing the signaling pathway linking hERG1 and PI3K, and can induce the formation of intracytoplasmic vacuoles and trigger apoptotic cell death in colorectal cancer (CRC) cells.
- Broad spectrum of antimicrobial activity
- Inhibits CYP3A4-catalyzed triazolam alpha-hydroxylation
- Significantly inhibits the hERG potassium current
- Affects autophagic flux by impairing the signaling pathway linking hERG1 and PI3K
- Induces intracytoplasmic vacuole formation
- Triggers apoptotic cell death in colorectal cancer cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.